Top Markets
#1 BOOK OF MEME BOOK OF MEME +26.80%
#2 XPIN Network XPIN Network +23.44%
#3 SSV Network SSV Network +22.92%
#4 The Black Bull The Black Bull +19.80%
#5 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +17.07%
#6 Bitcoin Cash Bitcoin Cash +16.56%
#7 Mubarak Mubarak +16.49%
#8 Geodnet Geodnet +16.21%
#9 Neiro Neiro +15.03%
#10 Derive Derive +13.77%
Coin of the day
BOOK OF MEME BOOK OF MEME
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Greenyn Biotechnology Co., Ltd Greenyn Biotechnology Co., Ltd

Greenyn Biotechnology Co., Ltd

6846
Classement en actions #25465
Greenyn Biotechnology Co., Ltd is an enterprise specializing in dietary... Greenyn Biotechnology Co., Ltd is an enterprise specializing in dietary supplements, dedicated to the development, production, and worldwide distribution of health-enhancing products. Their product portfolio includes a range of proprietary active ingredients. These feature notable components such as Insumate, derived from bitter melon extract; Antromax, which utilizes antrodia cinnamomea; and the Zymologist 101 Phyto fermented drink. Beyond individual ingredients, Greenyn provides an extensive selection of functional product series catering to a diverse array of health and wellness needs. These encompass solutions for youth and beauty, digestive and brain health, overall body regulation, throat care, hair care, vision support, and various lifestyle enhancement formulas. Additional ranges include joint health, general nutritional and energy supplementation, immune modulation, low-burden options, sleep assistance, body contouring, circulatory support, specific formulas for men's vitality and women's intimate health, and dedicated products for mature women. Moreover, the company extends its expertise through various services, including custom product development, Original Design Manufacturing (ODM), dosage form optimization, and application support. Established in 2012, the firm's operations are headquartered in Taichung, Taiwan.
Prix de l'action
$1.82
Capitalisation boursière
$49.32M
Changement (1 jour)
0.00%
Changement (1 an)
-25.53%
Pays
TW
Échange Greenyn Biotechnology Co., Ltd (6846)

Catégorie

Healthcare
Revenus pour Greenyn Biotechnology Co., Ltd (6846)
Revenus en Aug 2026 TTM : 0
Selon les derniers rapports financiers de Greenyn Biotechnology Co., Ltd, le chiffre d'affaires actuel de l'entreprise (TTM) est de 0. En 2026, l'entreprise a réalisé un chiffre d'affaires de 0 égal à le chiffre d'affaires de l'année 2026, qui était de 0. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Greenyn Biotechnology Co., Ltd de 2026 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
Pas assez de données pour les dates fournies.
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US